Vir Biotechnology Inc [VIR] stock is trading at $12.10, down -3.04%. An important factor to consider is whether the stock is rising or falling in short-term value. The VIR shares have gain 66.44% over the last week, with a monthly amount glided 38.76%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Vir Biotechnology Inc [NASDAQ: VIR] stock has seen the most recent analyst activity on January 29, 2024, when JP Morgan downgraded its rating to a Neutral and also revised its price target to $9 from $23. Previously, BofA Securities downgraded its rating to Neutral on September 08, 2023, and dropped its price target to $14. On March 06, 2023, upgrade upgraded it’s rating to Overweight and revised its price target to $34 on the stock. Goldman upgraded its rating to a Buy and increased its price target to $53 on February 21, 2023. Morgan Stanley upgraded its rating to a Equal-Weight and raised its price target to $30 on January 27, 2023. SVB Leerink started tracking with a Outperform rating for this stock on September 14, 2022, and assigned it a price target of $40. In a note dated September 09, 2022, Morgan Stanley initiated an Underweight rating and provided a target price of $15 on this stock.
Vir Biotechnology Inc [VIR] stock has fluctuated between $6.56 and $14.45 over the past year. Currently, Wall Street analysts expect the stock to reach $24 within the next 12 months. Vir Biotechnology Inc [NASDAQ: VIR] shares were valued at $12.10 at the most recent close of the market. An investor can expect a potential return of 98.35% based on the average VIR price forecast.
Analyzing the VIR fundamentals
Vir Biotechnology Inc [NASDAQ:VIR] reported sales of 78.62M for the trailing twelve months, which represents a drop of -9.81%. Gross Profit Margin for this corporation currently stands at 0.82% with Operating Profit Margin at -6.58%, Pretax Profit Margin comes in at -6.86%, and Net Profit Margin reading is -6.78%. To continue investigating profitability, this company’s Return on Assets is posted at -0.36, Equity is -0.37 and Total Capital is -0.37.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 11.50 points at the first support level, and at 10.90 for the second support level. However, for the 1st resistance point, the stock is sitting at 13.22, and for the 2nd resistance point, it is at 14.34.
Ratios To Look Out For
For context, Vir Biotechnology Inc’s Current Ratio is 8.94. On the other hand, the Quick Ratio is 8.94, and the Cash Ratio is 2.2. Considering the valuation of this stock, the price to sales ratio is 21.20, the price to book ratio is 1.33.
Transactions by insiders
Recent insider trading involved SATO VICKI L, Director, that happened on Jan 08 ’25 when 10960.0 shares were sold. Director, VICKI LEE SATO completed a deal on Jan 08 ’25 to buy 43840.0 shares. Meanwhile, EVP and General Counsel de Verneuil Vanina sold 76.0 shares on Dec 02 ’24.
